109 related articles for article (PubMed ID: 33714676)
1. The expression of microRNA-340 and cyclin D1 and its relationship with the clinicopathological characteristics and prognosis of lung cancer.
Fang L; Xu X; Zheng W; Wu L; Wan H
Asian J Surg; 2021 Nov; 44(11):1363-1369. PubMed ID: 33714676
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
Hwang SJ; Lee HW; Kim HR; Song HJ; Lee DH; Lee H; Shin CH; Joung JG; Kim DH; Joo KM; Kim HH
Oncotarget; 2015 Aug; 6(24):20434-48. PubMed ID: 25971210
[TBL] [Abstract][Full Text] [Related]
3. miR-466 Contributes to the Enhanced Antitumor Effect of Bortezomib on Non-Small-Cell Lung Cancer by Inhibiting CCND1.
Wang WH; Zhan JM; Tang YL; Zhou N; Liu WY; Jiang DW
Chemotherapy; 2022; 67(2):110-122. PubMed ID: 35042223
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
Chang W; Wang Y; Li W; Shi L; Geng Z
J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
[TBL] [Abstract][Full Text] [Related]
8. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
[TBL] [Abstract][Full Text] [Related]
9. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
Cui D; Qian R; Li Y
Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of miRNA-138 and cyclin D1 in oral lichen planus.
Ghallab NA; Kasem RF; El-Ghani SFA; Shaker OG
Clin Oral Investig; 2017 Nov; 21(8):2481-2491. PubMed ID: 28275859
[TBL] [Abstract][Full Text] [Related]
12. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
[TBL] [Abstract][Full Text] [Related]
13. Puerarin alleviates the progression of non-small cell lung cancer by regulating the miR-342/CCND1 axis.
Huang SR; Jin SS; Xu B; Wang RP
Neoplasma; 2020 Nov; 67(6):1244-1255. PubMed ID: 32749850
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NEAT1 accelerates breast cancer progression through regulating miR-410-3p/ CCND1 axis.
Liu X; Yao W; Xiong H; Li Q; Li Y
Cancer Biomark; 2020; 29(2):277-290. PubMed ID: 32675392
[TBL] [Abstract][Full Text] [Related]
15. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR‑193a‑3p via targeting cyclin D1 in thyroid cancer.
Li XJ; Wen R; Wen DY; Lin P; Pan DH; Zhang LJ; He Y; Shi L; Qin YY; Lai YH; Lai JN; Yang JL; Lai QQ; Wang J; Ma J; Yang H; Pang YY
Mol Med Rep; 2020 Sep; 22(3):2199-2218. PubMed ID: 32705210
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 is a major target of miR-206 in cell differentiation and transformation.
Alteri A; De Vito F; Messina G; Pompili M; Calconi A; Visca P; Mottolese M; Presutti C; Grossi M
Cell Cycle; 2013 Dec; 12(24):3781-90. PubMed ID: 24107628
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
[TBL] [Abstract][Full Text] [Related]
19. microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.
Chen Y; Jiang J; Zhao M; Luo X; Liang Z; Zhen Y; Fu Q; Deng X; Lin X; Li L; Luo R; Liu Z; Fang W
Oncotarget; 2016 Jul; 7(27):41306-41319. PubMed ID: 27191497
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-374b inhibits breast cancer progression through regulating CCND1 and TGFA genes.
Liu Y; Zhang A; Bao PP; Lin L; Wang Y; Wu H; Shu XO; Liu A; Cai Q
Carcinogenesis; 2021 Apr; 42(4):528-536. PubMed ID: 33480984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
